Atlas Trials

A Multicenter, Prospective, Phase II Study of Zanubrutinib for Maintenance in Patients With Mantle Cell Lymphoma

Clinical trial NCT06341556 · RECRUITING

Trial details

NCT number
NCT06341556
Sponsor
Fudan University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Mantle Cell LymphomaMaintenance Therapy
Start date
2024-05-24
Primary completion
2026-03-01
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.